SOX17 and cyclic hematopoiesis: To further evaluate the functional characteristics of SOX17-induced ECs, we introduced two control groups into our study: ECs differentiated from hPSCs through CHIR99021 treatment (referred to as CH-induced ECs)(Lian et al., 2014) and human umbilical vein ECs (HUVECs).